Servispor en es it fr

Servispor Brand names, Servispor Analogs

Servispor Brand Names Mixture

  • No information avaliable

Servispor Chemical_Formula

C16H17N3O4S

Servispor RX_link

http://www.rxlist.com/cgi/generic/cephalex.htm

Servispor fda sheet

Servispor FDA

Servispor msds (material safety sheet)

Servispor MSDS

Servispor Synthesis Reference

R. B. Morin, B. G. Jackson, U.S. Pat. 3,275,626,861 (1966,1970)

Servispor Molecular Weight

347.39 g/mol

Servispor Melting Point

326.8oC

Servispor H2O Solubility

1789 mg/L

Servispor State

Solid

Servispor LogP

0.019

Servispor Dosage Forms

Capsules (containing cephalexin monohydrate equivalent to 250 mg or 500 mg cephalexin); Tablet (containing cephalexin monohydrate equivalent to 250 mg or 500 mg of cephalexin); Suspension

Servispor Indication

For the treatment of respiratory tract infections caused by Streptococcus pneumoniae and Streptococcus pyogenes; otitis media due to Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Moraxella catarrhalis; skin and skin structure infections caused by Staphylococcus aureus and/or Streptococcus pyogenes; bone infections caused by Staphylococcus aureus and/or Proteus mirabilis; genitourinary tract infections, including acute prostatitis, caused by Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae.

Servispor Pharmacology

Cephalexin (also called Cefalexin) is a first generation cephalosporin antibiotic. It is one of the most widely prescribed antibiotics, often used for the treatment of superficial infections that result as complications of minor wounds or lacerations. It is effective against most gram-positive bacteria.

Servispor Absorption

Well absorbed from the gastrointestinal tract

Servispor side effects and Toxicity

Symptoms of overdose include blood in the urine, diarrhea, nausea, upper abdominal pain, and vomiting. The oral median lethal dose of cephalexin in rats is >5000 mg/kg.

Servispor Patient Information

Patients should be counseled that antibacterial drugs including Keflex should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Keflex is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Keflex or other antibacterial drugs in the future.

Servispor Organisms Affected

Enteric bacteria and other eubacteria